Inovio Pharmaceuticals
INO
1,28 €
Share price
0.68%
Change (1 day)
-87.29%
Change (1 year)
Categories
Inovio Pharmaceuticals (INO) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €31.07 Million
According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are €31.07 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €42.94 M | -11.42% |
| 2023-12-31 | €48.48 M | -58.78% |
| 2022-12-31 | €0.11 B | 38.37% |
| 2021-12-31 | €85 M | 32.97% |
| 2020-12-31 | €63.92 M | -48.31% |
| 2019-12-31 | €0.12 B | 220.97% |
| 2018-12-31 | €38.53 M | 3.31% |
| 2017-12-31 | €37.29 M | -22.05% |
| 2016-12-31 | €47.84 M | 38.01% |
| 2015-12-31 | €34.66 M | 108.25% |
| 2014-12-31 | €16.64 M | -35.02% |
| 2013-12-31 | €25.62 M | 229.65% |
| 2012-12-31 | €7.77 M | -23.79% |
| 2011-12-31 | €10.19 M | 51.3% |
| 2010-12-31 | €6.74 M | -50.33% |
| 2009-12-31 | €13.57 M | -4.57% |
| 2008-12-31 | €14.22 M | 137.57% |
| 2007-12-31 | €5.98 M | -36.55% |
| 2006-12-31 | €9.43 M | 102.88% |
| 2005-12-31 | €4.64 M | 16.76% |
| 2004-12-31 | €3.98 M | 324.4% |
| 2003-12-31 | €0.93 M | -42.09% |
| 2002-12-31 | €1.62 M | -14.34% |
| 2001-12-31 | €1.89 M | |
| 2001-03-31 | €1.82 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | €101.27 B | 325,787.86% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €99.69 B | 320,710.40% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | €0.76 B | 2,368.70% | 🇺🇸 USA |
 Novartis NVS | €53.04 B | 170,598.94% | 🇨🇭 Switzerland |
 Merck MRK | €57.56 B | 185,126.21% | 🇺🇸 USA |
 GlaxoSmithKline GSK | €52.44 B | 168,669.83% | 🇬🇧 UK |
 Gilead Sciences GILD | €32.22 B | 103,603.58% | 🇺🇸 USA |